The 2024 Biopharma Technology Landscape report by Benchling, a leading R&D cloud software company, reveals the transformative impact of artificial intelligence (AI) and automation on biopharma research and development (R&D). The report highlights how large biopharma companies are leveraging
The role of artificial intelligence (AI) in healthcare is expanding rapidly, and its application in prenatal care is proving to be a game-changer. Congenital heart defects (CHDs), the most common type of birth defect, often require early detection for timely intervention. Despite advancements in
The healthcare domain is witnessing a remarkable shift with the introduction of "TBorNotTB," a state-of-the-art clinical decision support system (CDSS) specifically designed for the evaluation of suspected tuberculosis (TB) cases in hospitals. The primary function of TBorNotTB is to aid
Telehealth companies are making significant strides in the healthcare industry by ramping up their advertising efforts and expanding into more complex areas of medicine. Initially known for providing low-stigma, easily accessible health products, these companies are now venturing into fields such
Depression is a pervasive mental health issue, affecting approximately 18 million Americans each year, with nearly 30% of the population experiencing it at some point in their lives. Despite guidelines recommending universal depression screening in primary care, the actual screening rates are
The creation and development of high-performance artificial neurons have marked a significant milestone in the field of advanced perception systems. This breakthrough, achieved through collaboration between Northwestern University and Georgia Tech, has led to the development of a novel
